Central East ATTC & PTTC Webinar Resources Page

Xylazine: Understanding the Latest Emerging Substance

July 25th, 2023

Access the recording here! 

This webinar was provided by the Central East ATTC and Central East PTTC. The Central East ATTC, MHTTC, and PTTC are programs managed by the Danya Institute.

Certificate of Attendance: Certificates of attendance must be requested within 7 days of the live event. Please allow up to 30 days for certificate requests to be processed. To be eligible for the certificate of attendance, you must have attended the live webinar on Zoom. 

PowerPoint Slides: Click on the green "View Slides" button above to view a PDF of today's webinar slides.

RESOURCES

• FACT SHEET: In Continued Fight Against Overdose Epidemic, the White House Releases National Response Plan to Address the Emerging Threat of Fentanyl Combined with Xylazine    
• CDC: What You Should Know About Xylazine
• ATTC & PTTC: Understanding Xylazine- An Emerging Concern  
• NIDA: Xylazine
• Philadelphia DOH: Health Alert- Risks of Xylazine Use and Withdrawal in People Who Use Drugs in Philadelphia
• UNC Street Drug Analysis Lab
• DEA: Emoji Drug Code | Decoded 
• DEA One Pill Can Kill: Parents & Caregivers Resources
• The Growing Threat of Xylazine and its Mixture with Illicit Drugs 
• Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022
• SAMHSA Harm Reduction Framework Draft Open for Comments Until August 14th

PRESENTERS

Jason Bienert, RN, CWCN  

[email protected]m

Josh Esrick, MPP

[email protected]

DRUG ENFORCEMENT AGENCY (DEA) GUEST: 

Gail Poirier

Section Chief, Strategic Intelligence Section (NIT)

[email protected]

Jaclyn Iera

Program Manager, Office of Forensic Sciences

[email protected]

SAMHSA:       

Jeanne Tuono

Assistant Regional Director (Region 3)